Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-15

FDA Approved: NILOTINIB — Original Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Torrent Pharmaceuticals Limited's original application for nilotinib, a generic version of the cancer drug Tasigna, for treatment of chronic my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nilotinib (nilotinib)

Snippet

ORIG AP for NILOTINIB (NILOTINIB)